OSCR vs CLOV vs ALHC vs ACGL vs BHVN

For growth investors, Alignment Healthcare, Inc.

(ALHC) is the stronger pick with 46. 1% revenue growth year-over-year, versus 14. 3% for Arch Capital Group Ltd. (ACGL). Arch Capital Group Ltd. (ACGL) offers the better valuation at 8. 1x trailing P/E (10. 0x forward), making it the more compelling value choice. Analysts rate Alignment Healthcare, Inc. (ALHC) a "Buy" — based on 16 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, Arch Capital Group Ltd.

is actually cheaper at 10. 0x.

Over the past 5 years, Arch Capital Group Ltd.

(ACGL) delivered a total return of +146. 7%, compared to -70. 5% for Clover Health Investments, Corp. (CLOV). Over 10 years, the gap is even starker: ACGL returned +320. 6% versus CLOV's -74. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Arch Capital Group Ltd.

(ACGL) is the lower-risk stock at 0. 02β versus Oscar Health, Inc. 's 1. 84β — meaning OSCR is approximately 11909% more volatile than ACGL relative to the S&P 500. On balance sheet safety, Arch Capital Group Ltd. (ACGL) carries a lower debt/equity ratio of 11% versus 5% for Biohaven Ltd. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Alignment Healthcare, Inc.

(ALHC) is pulling ahead at 46. 1% versus 14. 3% for Arch Capital Group Ltd. (ACGL). On earnings-per-share growth, the picture is similar: Alignment Healthcare, Inc. grew EPS 99. 4% year-over-year, compared to -1865. 9% for Oscar Health, Inc.. Over a 3-year CAGR, OSCR leads at 41. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Arch Capital Group Ltd.

(ACGL) is the more profitable company, earning 22. 1% net margin versus -4. 4% for Clover Health Investments, Corp. — meaning it keeps 22. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ACGL leads at 25. 0% versus -4. 4% for CLOV. At the gross margin level — before operating expenses — CLOV leads at 103. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Arch Capital Group Ltd.

(ACGL) trades at 10. 0x forward P/E versus 141. 3x for Alignment Healthcare, Inc. — 131. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BHVN: 119. 3% to $21. 29.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Arch Capital Group Ltd.

(ACGL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 02), +320. 6% 10Y return). Oscar Health, Inc. (OSCR) carries a higher beta of 1. 84 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ACGL: +320. 6%, OSCR: -48. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (OSCR (Healthcare) and CLOV (Healthcare) and ALHC (Healthcare) and ACGL (Financial Services) and BHVN (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: OSCR is a small-cap high-growth stock; CLOV is a small-cap high-growth stock; ALHC is a small-cap high-growth stock; ACGL is a mid-cap deep-value stock; BHVN is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.